Topicort
NDC Package 51672-5202-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Topicort is desoximetasone is used to treat a type of skin condition (plaque psoriasis). Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-5202 and is authorized under FDA application ANDA074904.

Identification & Billing

NDC Package Code
51672-5202-3
Package Description
1 TUBE in 1 CARTON / 60 g in 1 TUBE
Product Code
51672-5202
11-Digit Billing Format
51672520203
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
60 GM

Clinical Specifications

Proprietary Name
Topicort
Dosage Form
-
Usage Information
Desoximetasone is used to treat a type of skin condition (plaque psoriasis). It reduces the swelling, itching, and redness that may occur with plaque psoriasis. This medication is a strong corticosteroid.

Regulatory & Marketing

Labeler Name
Sun Pharmaceutical Industries, Inc.
FDA Application #
ANDA074904
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-14-1998
End Marketing Date
05-23-2024
Listing Expiration
05-23-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (51672-5202). Click a package code to view its specific billing and regulatory data.

51672-5202-1
1 TUBE in 1 CARTON / 15 g in 1 TUBE
51672-5202-2
1 TUBE in 1 CARTON / 30 g in 1 TUBE
51672-5202-5
5 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51672-5202-3 identifies a specific commercial package of 1 tube in 1 carton / 60 g in 1 tube of Topicort, labeled by Sun Pharmaceutical Industries, Inc.. This product is billed per "GM" gram and contains an estimated amount of 60 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on July 14, 1998. The current certification is valid through May 23, 2024.

What are the primary indications for this medication?

Desoximetasone is used to treat a type of skin condition (plaque psoriasis). It reduces the swelling, itching, and redness that may occur with plaque psoriasis. This medication is a strong corticosteroid.

How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672520203. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51672-5202-3
11-Digit CMS (5-4-2)
51672-5202-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.